BACKGROUND: Current practice guidelines advocate delaying assessment of primary prevention implantable cardioverter/defibrillator (ICD) candidacy at least 40 days after an acute myocardial infarction (AMI) because early ICD implantation after AMI has not demonstrated survival benefit. The rate at which interval reassessment of left ventricular ejection fraction (LVEF) occurs in potential primary prevention ICD candidates is unknown. METHODS: We examined patients with AMI in the TRIUMPH registry with inhospital LVEF <40% discharged alive after their index presentation, excluding patients with a prior ICD and those who declined ICD during the index admission or were discharged to hospice. We conducted multivariable Poisson modeling to identify independent factors associated with LVEF reassessment by 6 months after AMI. RESULTS: Of the 533 patients meeting the inclusion criteria, only 187 (35.1%) reported LVEF reassessment in the first 6 months after AMI and only 13 patients (2.4%) underwent ICD implantation by 1 year. In multivariable analysis, early cardiology follow-up after AMI was associated with a higher likelihood of LVEF reassessment (odds ratio 1.16, 95% confidence interval 1.06-1.28), whereas uninsured status and cardiologist-driving inpatient medical decision making were associated with a lower likelihood of LVEF reassessment (odds ratios 0.84 [95% CI 0.74-0.96] and 0.78 [95% CI 0.68-0.91], respectively). CONCLUSIONS: In contemporary practice, almost 2 of 3 potential primary prevention ICD candidates did not report follow-up LVEF evaluation, with a very low rate of ICD implantation at 1 year. These results suggest an important gap in quality, highlighting the need for better transitions of care.
RCT Entities:
BACKGROUND: Current practice guidelines advocate delaying assessment of primary prevention implantable cardioverter/defibrillator (ICD) candidacy at least 40 days after an acute myocardial infarction (AMI) because early ICD implantation after AMI has not demonstrated survival benefit. The rate at which interval reassessment of left ventricular ejection fraction (LVEF) occurs in potential primary prevention ICD candidates is unknown. METHODS: We examined patients with AMI in the TRIUMPH registry with inhospital LVEF <40% discharged alive after their index presentation, excluding patients with a prior ICD and those who declined ICD during the index admission or were discharged to hospice. We conducted multivariable Poisson modeling to identify independent factors associated with LVEF reassessment by 6 months after AMI. RESULTS: Of the 533 patients meeting the inclusion criteria, only 187 (35.1%) reported LVEF reassessment in the first 6 months after AMI and only 13 patients (2.4%) underwent ICD implantation by 1 year. In multivariable analysis, early cardiology follow-up after AMI was associated with a higher likelihood of LVEF reassessment (odds ratio 1.16, 95% confidence interval 1.06-1.28), whereas uninsured status and cardiologist-driving inpatient medical decision making were associated with a lower likelihood of LVEF reassessment (odds ratios 0.84 [95% CI 0.74-0.96] and 0.78 [95% CI 0.68-0.91], respectively). CONCLUSIONS: In contemporary practice, almost 2 of 3 potential primary prevention ICD candidates did not report follow-up LVEF evaluation, with a very low rate of ICD implantation at 1 year. These results suggest an important gap in quality, highlighting the need for better transitions of care.
Authors: Ratika Parkash; John L Sapp; Magdy Basta; Steve Doucette; Kara Thompson; Martin Gardner; Chris Gray; Brenda Brownell; Hena Kidwai; Jafna Cox Journal: Circ Arrhythm Electrophysiol Date: 2012-06-08
Authors: Stefan H Hohnloser; Karl Heinz Kuck; Paul Dorian; Robin S Roberts; John R Hampton; Robert Hatala; Eric Fain; Michael Gent; Stuart J Connolly Journal: N Engl J Med Date: 2004-12-09 Impact factor: 91.245
Authors: Scott D Solomon; Steve Zelenkofske; John J V McMurray; Peter V Finn; Eric Velazquez; George Ertl; Adam Harsanyi; Jean L Rouleau; Aldo Maggioni; Lars Kober; Harvey White; Frans Van de Werf; Karen Pieper; Robert M Califf; Marc A Pfeffer Journal: N Engl J Med Date: 2005-06-23 Impact factor: 91.245
Authors: P Michael Ho; Stacie A Luther; Frederick A Masoudi; Indra Gupta; Elliott Lowy; Charles Maynard; Anne E Sales; Eric D Peterson; Stephan D Fihn; John S Rumsfeld Journal: Am Heart J Date: 2007-09 Impact factor: 4.749
Authors: Kevin L Thomas; Sana M Al-Khatib; Richard C Kelsey; Heather Bush; Lynne Brosius; Eric J Velazquez; Eric D Peterson; F Roosevelt Gilliam Journal: Am J Cardiol Date: 2007-06-27 Impact factor: 2.778
Authors: Lesley H Curtis; Sana M Al-Khatib; Alisa M Shea; Bradley G Hammill; Adrian F Hernandez; Kevin A Schulman Journal: JAMA Date: 2007-10-03 Impact factor: 56.272
Authors: Youngjin Cho; Sang Yeong Cho; Il Young Oh; Ji Hyun Lee; Jin Joo Park; Hae Young Lee; Kye Hun Kim; Byung Su Yoo; Seok Min Kang; Sang Hong Baek; Eun Seok Jeon; Jae Joong Kim; Myeong Chan Cho; Shung Chull Chae; Byung Hee Oh; Dong Ju Choi Journal: J Korean Med Sci Date: 2020-11-30 Impact factor: 2.153
Authors: Stephen B Wilton; Matthew T Bennett; Ratika Parkash; Katherine Kavanagh; E Marc Jolicoeur; Frank Halperin; Umjeet Jolly; Peter Leong-Sit; Rozsa Sas; Derek S Chew; Sarah Singh; Stephanie Frisbee; Robert MacLachlan; Jaimie Manlucu Journal: JAMA Netw Open Date: 2021-12-01